Featured Article

Update on ICH E6 (R2) Guideline for GCP

The ICH E6 R2 Addendum is starting to have a significant, positive impact on clinical trial design – offering a real opportunity to inject efficiencies into clinical research and development.

Guide

NEW: The Ultimate Guide to Modern, Regulatory-Grade RBQM

Press Release
CluePoints Shortlisted for 2026 Scrip Awards Following 2023 and 2025 Wins
Press Release
CluePoints Launches Three AI-Led Clinical Data Review Capabilities, Co-Innovated with a Top 10 Pharmaceutical Company
Press Release
CluePoints Appoints Martin Magazzolo as Chief Commercial Officer